Results 111 to 120 of about 5,879 (222)

Selection and Characterization of Single Domain Antibodies Specific for Bacillus anthracis Spore Proteins

open access: yesAntibodies, 2013
To obtain thermostable immunoreagents specific for the spore form of Bacillus anthracis two llamas were immunized with a combination of six different recombinant proteins.
P. Audrey Brozozog Lee   +3 more
doaj   +1 more source

Hevea genetic transformation using a single-chain variable fragment (scFv) specific to cassiicolin, the causal agent of Corynespora leaf disease [PDF]

open access: yes, 2011
The pathogenic fungus Corynespora cassiicola a serious threat to rubber trees (Hevea brasiliensis); the infected leaves develop necrotic lesions and abscise, leaving the tree unproductive. The destructiveness of C.
Ezam Badarudin, Badrul   +6 more
core  

A Human-Derived Monoclonal Antibody Targeting Extracellular Connexin Domain Selectively Modulates Hemichannel Function [PDF]

open access: yes, 2019
Connexin hemichannels, which are plasma membrane hexameric channels (connexons) composed of connexin protein protomers, have been implicated in a host of physiological processes and pathological conditions. A number of single point pathological mutations
Buratto, Damiano   +12 more
core   +1 more source

Identification And Characterization Of A Novel Anti-Viral Peptide Against Avian Influenza Virus H9n2 [PDF]

open access: yes, 2009
Avian influenza viruses (AIV) are major cause of morbidity and mortality in the world. It is the causative agent of the most dangerous disease, called bird flu in common terms, among poultries.
Rajik, Mohamed
core  

biopanning

open access: yes
Citation: 'biopanning' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.12950 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source

Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligands

open access: yesJournal of Drug Targeting, 2007
Intravenous targeting of anticancer agents should improve both efficacy and therapeutic index. However, rational design of targeting constructs requires detailed definition of receptor targets and must take account of polarised tissue architecture that may restrict access to chosen receptors from the bloodstream.
Maruta, F   +9 more
openaire   +3 more sources

Preparation of Phage Display cDNA Libraries for Identifying Immunogenic Tumor Antigens: Challenges in Functional cDNA Presentation and Approaches to Overcoming Them

open access: yesViruses
Cancer continues to represent a substantial burden in terms of its morbidity and mortality, underscoring the imperative for the development of novel and efficacious treatment modalities.
Nuša Brišar   +2 more
doaj   +1 more source

Construction of a Single Chain Variable Fragment Against Mcf-7 Breast Cancer Cells [PDF]

open access: yes, 2008
Recombinant antibody cloning and phage display technologies can be employed to produce and isolate single-chain antibodies (scFv) specifically against antigen of interest.
Ahmad, Zuhaida Asra
core  

Development and molecular analyses of Xanthomonas pthA specific scFv recombinant monoclonal antibodies

open access: yesJournal of Crop Protection, 2019
The Xanthomonas citri pv. citri (Xcc) is causal agent of bacterial citrus canker which is major disease of citrus throughout the world. The pthA bacterial effector protein is presented within the infected plants and indispensable of canker.
Hamideh Raeisi   +6 more
doaj  

Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases

open access: yesMolecules
In recent years, phage display technology has become vital in clinical research. It helps create antibodies that can specifically bind to complex antigens, which is crucial for identifying biomarkers and improving diagnostics and treatments.
Mohammad Sadraeian   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy